News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imagion Biosystems.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Imagion jumps 20pc after delivering positive Phase 1 results
News
Top 10 at 10: These ASX biotech, gold, copper and lithium stocks are clear punter favourites at the opening bell
News
Market Highlights: More recession talks on Wall Street, and 5 ASX small caps to watch on Thursday
Investor Guides
Investor Guide: Health & Biotech FY2023
News
ASX Small Cap Lunch Wrap: Who’s got a new take on an old favourite today?
Health & Biotech
Dr Boreham’s Crucible: With two new partners, can Imagion shake off Covid-interrupted syndrome?
Health & Biotech
Check Up: Imagion and Invion both target breast cancer clinical trials
Health & Biotech
ASX Health Stocks: Imugene up on PD1-Vaxx cancer study expansion plans
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
Weekly ASX Small Cap Wrap: More crocs spotted in the wild
News
Bhavdip143 just told us why Twitter banned him; pledges to keep posting
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s on target for their best month in 32 years?
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Check up: A good fortnight to be a small cap health investor
News
Closing Bell: Today’s biggest small cap movers on the ASX
News